Table 1 Univariate analysis of factors associated with overall survival
From: KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
Variables | Hazard ratio (95%CI) | P-value |
|---|---|---|
Age(years) | 0.5579 (0.3431 to 0.9073) | 0.0196 |
 < 50 | ||
 ≧50 | ||
Tumour size(cm) | 0.9748(0.5803 to 1.638) | 0.0109 |
 < 3 | ||
 ≧3 | ||
Histology WHO | 0.04285 (0.02234 to 0.08218) | < 0.0001 |
 I/II | ||
 III/IV | ||
KPS | 0.5097 (0.3145 to 0.8261) | 0.0002 |
 <=80 | ||
 > 80 | ||
Chemotherapy | 0.8774 (0.5482 to 1.404) | 0.9565 |
 yes | ||
 no | ||
radiation therapy | 0.9376 (0.5714 to 1.539) | 0.3189 |
 yes | ||
 no | ||
ki-67 | 0.1614 (0.09453 to 0.2756) | < 0.0001 |
 Negative | ||
 Positive | ||
KPNA2 | 0.5861 (0.2461 to 0.9832) | < 0.0001 |
 <8 | ||
 ≥8 |